You are here
Prices & Quotes - UK Markets - GlaxoSmithKline (GSK)
Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.
- Change Today:
-
-0.40p
- Market Cap:
- £61,570m
- Sector:
- Pharmaceuticals & Biotechnology
GlaxoSmithKline Overview
UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
GlaxoSmithKline Fundamentals
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-16 | 27,889.00 | 1,939.00 | 102.40p | 15.3 | 0.4 | +35% | 80.00p | 5.1% |
31-Dec-17 | 30,186.00 | 3,525.00 | 111.80p | 11.8 | 1.3 | +9% | 80.00p | 6.0% |
31-Dec-18 | 30,821.00 | 4,800.00 | 119.40p | 12.5 | 1.8 | +7% | 80.00p | 5.4% |
31-Dec-19 | 33,754.00 | 6,221.00 | 123.90p | 14.4 | 3.6 | +4% | 80.00p | 4.5% |
31-Dec-20 | 34,099.00 | 6,968.00 | 115.90p | 11.6 | n/a | -6% | 80.00p | 6.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
GlaxoSmithKline ShareCast News
Thursday broker round-up | 04-Mar-2021 | ShareCast |
GSK Covid-19 monoclonal treatment shows potentia... | 25-Feb-2021 | ShareCast |
GSK, Vir to collaborate on new therapeutics for ... | 17-Feb-2021 | ShareCast |
GlaxoSmithKline Market Data
Currency | UK Pounds |
Price | 1,223.80p |
Change Today | -0.40p |
52 Week High | 1,742.20p |
52 Week Low | 1,190.80p |
Volume | 2,111,464 |
Shares Issued | 5,031m |
Market Cap | £61,570m |
Performance Indicators
- Value
-
- market
-
- full market star
- full market star
- full market star
- full market star
- half market star
-
- sector
-
- full sector star
- full sector star
- full sector star
- full sector star
- full sector star
- Price Trend
-
- market
-
- empty market
- empty market
- empty market
- empty market
- empty market
-
- sector
-
- empty sector
- empty sector
- empty sector
- empty sector
- empty sector
- Income
-
- market
-
- full market star
- full market star
- full market star
- full market star
- half market star
-
- sector
-
- full sector star
- full sector star
- full sector star
- full sector star
- full sector star
- Growth
-
- market
-
- full market star
- full market star
- half market star
- empty market
- empty market
-
- sector
-
- half sector star
- empty sector
- empty sector
- empty sector
- empty sector
- Price Chg 6m
-
- market
-
- half market star
- empty market
- empty market
- empty market
- empty market
-
- sector
-
- full sector star
- empty sector
- empty sector
- empty sector
- empty sector
- P/E
-
- market
-
- full market star
- full market star
- full market star
- half market star
- empty market
-
- sector
-
- full sector star
- full sector star
- full sector star
- full sector star
- half sector star
- PEG
-
- market
-
- full market star
- full market star
- full market star
- full market star
- empty market
-
- sector
-
- full sector star
- full sector star
- full sector star
- full sector star
- half sector star
- Dividend Yield
-
- market
-
- full market star
- full market star
- full market star
- full market star
- empty market
-
- sector
-
- full sector star
- full sector star
- full sector star
- full sector star
- full sector star
- EPS Growth
-
- market
-
- full market star
- full market star
- empty market
- empty market
- empty market
-
- sector
-
- full sector star
- empty sector
- empty sector
- empty sector
- empty sector
What The Brokers Say
Strong Buy | 10 |
Buy | 0 |
Neutral | 12 |
Sell | 0 |
Strong Sell | 3 |
Total | 25 |

Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
GlaxoSmithKline Dividends
Latest | Previous | |
---|---|---|
Q4 | Q3 | |
Ex-Div | 18-Feb-21 | 12-Nov-20 |
Paid | 08-Apr-21 | 14-Jan-21 |
Amount | 23.00p | 19.00p |
Trades for 05-Mar-2021
Time | Volume / Share Price |
13:15 | 159 @ 1,223.80p |
13:15 | 94 @ 1,223.80p |
13:15 | 171 @ 1,223.60p |
13:15 | 452 @ 1,223.60p |
13:15 | 66 @ 1,223.60p |
GlaxoSmithKline Key Personnel
CEO | Emma Walmsley |
CFO | Iain Mackay |